The World Health Organisation has identified the Covid-19 vaccine candidates developed by Oxford University-AstraZeneca and Moderna Inc as the front-runners <br /> <br />Even though there are more than 13 experimental vaccines in clinical trials among the 140 being developed to combat Covid-19, the World Health Organisation has identified the candidates developed by Oxford University-AstraZeneca and Moderna Inc as the front-runners. <br /> <br />“Certainly in terms of how advanced they are, the stage at which they are, they are I think probably the leading candidate,” Reuters quoted WHO chief scientist Soumya Swaminathan as saying. <br /> <br />“We do know that Moderna’s vaccine is also going to go into phase three clinical trials, probably from the middle of July, and so that vaccine candidate is not far behind. <br /> <br />AstraZeneca certainly has a more global scope at the moment in terms of where they are doing and planning their vaccine trials,” Swaminathan said. <br /> <br />Oxford University-AstraZeneca coronavirus vaccine <br />A
